Navigation Links
Pomegranates Found To Slow Prostate Cancer Progression

Prostate is a walnut sized gland present below the urinary bladder in males. The main function of the gland is to produce secretions that add volume to the semen//. Prostate cancer is the most common cancer diagnosed and is the second leading cause of cancer death in American men. The incidence of the cancer in Asian men is comparatively lower.

With respect to cancer prevention, an assessment of the risk factors is important. It is equally important to know about agents that offer protection against prostate cancer. Substances like lycopene (found in tomato sauce), Selenium have been found to be associated with reduced risk. A new addition has been made in the above category following the discovery that pomegranate juice may ward off prostate cancer.

Pomegranates are packed with healthy anti-oxidants and anti-inflammatory agents. Earlier research had shown that pomegranate extract is effective against tumours in mouse skin. In tests on mice, the juice dramatically slowed down the growth of prostate cancer cells.

The human prostate cancer cell lines were treated with the under experimental conditions. It was found that the extract killed the cancer cells in a dose-dependent way. The higher the dose of pomegranate juice, the more tumour cells died.

Next the tests were conducted on mice injected with prostate cancer cells taken from humans. A total of 24 mice were divided into three groups. One was given normal water to drink, while the others had their water supplemented with 0.1% or 0.2% of pomegranate juice. The doses were chosen to mirror how much juice a typically healthy person might be willing to consume daily.

The results were dramatic characterized by significantly lower cancer progression in mice receiving the higher pomegranate dose. Furthermore, blood tests revealed decreased levels of prostate-specific antigen (PSA), a marker commonly used to monitor prostate cancer.
'"/>




Page: 1

Related medicine news :

1. Pomegranates In Snack-Sized Bars
2. Fluoride Found Effective in Osteoporosis
3. Implantable Contact Lens Found Safe and Effective
4. Cancer hazard Found With Animal-Based Nutrients
5. Processed Meat, Diabetes connection Found
6. Night Time Aspirin Regimen Found to Reduce Blood Pressure
7. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
8. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
9. Preventive Therapies Found to be More Effective in Managing Migraines
10. Common Cold Found to Fight Cancer
11. Circumcision Found To Prevent HIV Spread
Post Your Comments:
(Date:12/2/2008)...Newswire/ -- diaDexus, Inc. today,announced that ...mat of the,PLAC Test for Lp-PLA2. This automated ... a wide range of clinical chemistry analyzers, was...tration (FDA) in December 2007. diaDexus also,ann...st to Europe. , The PLAC Test is the only b...
(Date:12/2/2008)...t a symposium today hosted by Johns,Hopkins Univ...archers presented,the latest research in brain pl...cience into technology to improve lives. Henry Mah...vidence that cognitive intervention developed by,...brain,s ability to,reorganize itself throughout l...
(Date:12/2/2008)...ewswire/ -- Are you unhappy with your smile but ar...ailable? , , The Pennsylvania Dental Associ...ptions exist to improve your smile. Your dentist c... determine a suitable option to help restore your ...tal options. , , , , Tooth whi...
(Date:12/2/2008)...ed for 3.5 percent of high school athletes, injuri... to examine rare injuries and conditions of U.S. h...uries, dental injuries, neck and cervical injuries...t in high morbidity, costly surgeries and treatmen... associated with the highest rate of rare injuries...
Breaking Medicine News(10 mins):Health News:diaDexus Receives CE Mark Certification for the PLAC(R) Test 2Health News:Posit Science Invited to Speak at Johns Hopkins University About Cutting Edge Cognitive Training Interventions 2Health News:Cosmetic Dentistry: A Beautiful Smile Is Not Far Away 2
...riggered by viral cold are common in preschoolers....since the frequency disappears by school age. //Th...r oral steroids at the first sign of an attack. Bu...ive is controversial. The research shows a course...
...be a major improvement for HIV patients in less-de...sess a patient's response to HIV medication.// HIV... This treatment is now becoming available in Afric...etermine the CD4 cell count are needed. A low CD4 ...
...to help acne patients. A new study highlights the ...is is important because this skin disease can lead...b and sometimes even suicide. Doctors from London ...ate facial acne. Thirty-one of the patients receiv...
...is year’s meeting of the American Society of Thera...ment //of external beam radiation may be what it t...ers that have spread to the bone. More than 160 ho... States and Canada were involved in a study of abo...
Other Medicine News:
(Date:12/1/2008)...st policy , , ROCHESTER, Minn., Dec. 1 /PR...ic finds the use of the drug therapy etanercept in...e inflammation of the liver caused by excessive co... published in the December issue of Gastroenterol... VIDEO ALERT: Additional audio and video resource...
(Date:12/1/2008)...rstCall/ -- Vical Incorporated (Nasdaq: VICL ) a...tone payment from Merck & Co., Inc. based on M...ial of an investigational plasmid DNA (pDNA) cance...,s DNA gene delivery technology and encodes human ... the subject of separate license agreement. , ...
(Date:11/27/2008)...acute lymphoblastic leukemia relapse cases arise f...s , , MEMPHIS, Tenn., Nov. 27 /PRNewswire-U...search Hospital have identified distinctive geneti...te lymphoblastic leukemia (ALL) that cause relapse...ents for ALL relapse in children and, ultimately, ...
(Date:11/25/2008)...wire-USNewswire/ -- Kleinert Kutz and University ....S. hand transplant on Messina, New York resident,...tal Hand Care Center on Monday, November 24. The ...pleted shortly after 9 p.m. in a record nine hours...bin/prnh/20081125/DC48555-a ) , (Photo: http:...
Breaking Medicine Technology:Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Oracle Healthcare Acquisition Corp Announces Stockholder Approval of Proposed Dissolution and Plan of Liquidation 18720 1Oracle Healthcare Acquisition Corp Announces Stockholder Approval of Proposed Dissolution and Plan of Liquidation 18720 2Memory Pharmaceuticals to Announce First Quarter 2008 Results on Wednesday May 14 2008 5202 1FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation 5200 1FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation 5200 2FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation 5200 3ImaRx Schedules Release of First Quarter 2008 Financial Results 5198 1
...007 – Intercell AG (VSE,“ICLL”)...& Co., Inc. on the results of a Phase I study ...rs comparing safety and,immunogenicity of differen...he Staphylococcus aureus vaccine is based on a con...uo;s Antigen Identification,Program (AIP®) and...
...2007 /PRNewswire-FirstCall/ -- A total,of 20 oral ...Schering-Plough,s hepatitis products, including PE... (ribavirin, USP) combination,therapy for chronic ...previr (SCH 503034), the company,s investigational... clinical development, will,be presented by leadin...
Other Medicine Technology:Staphylococcus aureus vaccine development on track ? safe and,immunogenic in Phase I clinicaltrials 2Staphylococcus aureus vaccine development on track ? safe and,immunogenic in Phase I clinicaltrials 3Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 2Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 3Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 4Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 5Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 6Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 7
... integrated technology and service--mobile,outpati...heartbeat, ECG monitoring, analysis and response, ...y focused on helping physicians diagnose and treat...in diagnosing and treating arrhythmia. Delays can ...
...rmance temperature controlled shaker which accommo...eed and incubation time are fully programmable via...ed on the LCD in real time. Microprocessor-control... provide uniform incubation with less than 0.6 C v...
The iEMS Incubator/Shaker HT is designed for extended temperatures. Thus, the iEMS Incubator/Shaker HT is ideal for applications such as DNA hybridization and primer extension assays. iEMS Incubator/
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -
Medicine Products: